Artificial Intelligence (AI) is playing a significant role in the early detection of cancer and accelerating new drug ...

Dr. Reddy's (RDY) partners with Shanghai Henlius Biotech to develop and market biosimilar versions of J&J's (JNJ) multiple myeloma therapy Darzalex. Read more here.

The Hyderabad-based drug major Dr Reddy's Laboratories had reported a profit of Rs 1,379 crore for the October-December period of last fiscal. Revenue increased to Rs 8,359 crore in the quarter from ...

Stock Market Today: Dr Reddy's Laboratories share price declined more than 6% in the morning trades on Friday post-Q3 results that were announced after the market hours of Thursday. On Thursday ...

Dr Reddy's Labs Q3 FY25 net profit beat Street estimates, rising 2.5 percent year-on-year to Rs 1,413.3 crore, helped by a contribution from the recently acquired NRT business. The pharma major's ...

(Image: Freepik) Dr Reddy’s Lab share prices fell 5.5% to a low of Rs 1,218 as soon as the scrip started trading on the National Stock Exchanges on January 24. The dip in the share price of Dr ...

Hyderabad: Dr D. Nageshwar Reddy, founder and chairman of AIG Hospitals, on Saturday became the first medical doctor to be bestowed with all three Padma awards — Padma Shri in 2002, Padma ...

Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1 (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...

While drugmaker Dr Reddy's Laboratories' Q3 earnings were slightly above the Street's estimates, the highlight of the show was declining revenue contribution from Revlimid, which also weighed on ...

PSAI Business Revenue: USD97 million, 3% YoY growth, 3% QoQ decline. Dr Reddy's Laboratories Ltd (NYSE:RDY) reported a double-digit top line growth of 16% year-on-year, driven by strong ...

Zerodha co-founder Nithin Kamath sees the trend of rising credit card and personal loans and ballooning debt in the next two quarters, which will likely result in a surge in default, uprooting the ...

The revenue from operations for the said quarter came in at ₹8,358.6 crore, recording a 16% YoY jump versus ₹7,214.8 crore posted in the December 2023 quarter. The growth was largely driven by ...